Market Tracker

07/23 7:39am ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

9.07
Data as of Jul 22
 -0.01 / -0.11%
Today’s Change
6.51
Today|||52-Week Range
18.18
-39.49%
Year-to-Date

Today’s Trading

Previous close9.08
Today’s open9.16
Day’s range8.99 - 9.27
Volume784,226
Average volume (3 months)1,819,550
Market cap$1.1B
Dividend yield--
Data as of 07/22/2014

Growth & Valuation

Earnings growth (last year)-54.17%
Earnings growth (this year)+13.90%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.47%
P/E ratioNM
Price/Sales30.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.02+0.47%
IMGNImmunoGen Inc+0.14+1.25%
BLUEbluebird bio Inc+0.47+1.38%
OPHTOphthotech Corp-0.35-0.84%
Data as of 07/22/2014

Financials

Next reporting dateAugust 8, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.8M
Annual profit (last year)-$83.5M
Net profit margin-152.33%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts